Recently, Hengsai Biotech completed the first round of strategic financing, which was exclusively invested by Tianshili Capital. This round of funding will mainly be used to promote R&D and clinical trials of the core pipeline and the company's international strategic layout.

Recently, Hengsai Biotech completed the first round of strategic financing, which was exclusively invested by Tianshili Capital. This round of funding will mainly be used to promote R&D and clinical trials of the core pipeline and the company's international strategic layout.